Jounce Therapeutics was founded in 2013 by three leading immuno-oncology experts, Richard Murray, Ph.D., Gordon Freeman, Ph.D. and Glenn Dranoff, M.D. Jounce is based on more than a decade of groundbreaking research at the Dana-Farber Cancer Institute and Harvard Medical School.
